<![CDATA[Background: Keloids are fibroproliferative scars characterized by excessive collagen deposition, high recurrence rates, and variable responses to conventional therapies. Objective: This study aims to examine the effectiveness of various laser therapy modalities in keloid management and evaluate the potential of laser therapy as an effective treatment option with minimal adverse effects. Methods: This study employed a literature review method by examining scientific publications related to the use of laser therapy for keloids. The analysis focused on the effectiveness of several laser modalities, including pulsed dye laser (PDL), neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, carbon dioxide (CO₂) laser, and fractional laser therapy, in reducing keloid size and improving patient satisfaction. Results: PDL reduced keloid size by up to 72% with minimal recurrence, while Nd:YAG laser therapy reduced lesion size to approximately 10% within four weeks. CO₂ laser therapy promoted tissue remodeling through thermal effects, and fractional laser therapy achieved a 96.7% patient satisfaction rate with significant improvements in Vancouver Scar Scale scores. Overall, laser modalities demonstrated varying mechanisms of action and therapeutic effectiveness, supporting the need for individualized treatment selection. Conclusion: Laser therapy is an effective option for keloid management, reducing scar size and improving scar quality with high patient satisfaction and minimal adverse effects. However, because recurrence remains a significant challenge, a multimodal treatment approach is still recommended.]]>
